advertisement
Chen MY 7
Showing records 1 to 7 | Display all abstracts from Chen MY106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Sun X
Ophthalmology and therapy 2023; 12: 341-353
106917 Microinvasive glaucoma surgeries: critical summary of clinical trial data with and without phacoemulsification
Aref AA
Current Opinions in Ophthalmology 2023; 34: 146-151
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Yao K
Ophthalmology and therapy 2023; 12: 341-353
106917 Microinvasive glaucoma surgeries: critical summary of clinical trial data with and without phacoemulsification
Parker PR
Current Opinions in Ophthalmology 2023; 34: 146-151
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Liu Q
Ophthalmology and therapy 2023; 12: 341-353
106917 Microinvasive glaucoma surgeries: critical summary of clinical trial data with and without phacoemulsification
Chen MY
Current Opinions in Ophthalmology 2023; 34: 146-151
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Zhang H; Xing X; Fang A; Duan X; Yu M; Chen MY; Yang J; Goodkin ML
Ophthalmology and therapy 2023; 12: 341-353